| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 4.76e-06 | 12 | 209 | 4 | GO:0002924 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.69e-05 | 16 | 209 | 4 | GO:0002890 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.69e-05 | 16 | 209 | 4 | GO:0002713 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 CDHR5 IGSF9 DSCAM PCDHGB6 PCDHGB5 PCDHGB1 NECTIN3 PCDHGB4 IGSF21 | 2.19e-05 | 187 | 209 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 3.52e-05 | 19 | 209 | 4 | GO:0002921 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 3.86e-05 | 62 | 209 | 6 | GO:0002455 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 5.53e-05 | 8 | 209 | 3 | GO:0045959 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 6.49e-05 | 22 | 209 | 4 | GO:0002923 | |
| GeneOntologyBiologicalProcess | medium-chain fatty acid transport | 1.02e-04 | 2 | 209 | 2 | GO:0001579 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 1.17e-04 | 10 | 209 | 3 | GO:0030450 | |
| GeneOntologyCellularComponent | external side of plasma membrane | CEACAM5 ITGAD ITGAE ITGAM ITGAX MFGE8 FCRL3 ACKR3 PLAU PLG ENOX2 CUBN CR2 LDLR CSF2RA RNPEP CD86 LPA FCRL4 LY9 IGSF21 FCMR | 2.23e-08 | 519 | 215 | 22 | GO:0009897 |
| GeneOntologyCellularComponent | side of membrane | CEACAM5 ITGAD ITGAE ITGAM ITGAX MFGE8 FCRL3 DST ACKR3 PLAU PLG ENOX2 CUBN CR2 LDLR CSF2RA RNPEP CD86 LPA FCRL4 LY9 MAP2K2 IGSF21 FCMR | 1.25e-05 | 875 | 215 | 24 | GO:0098552 |
| GeneOntologyCellularComponent | cell surface | CEACAM5 ITGAD ITGAE ITGAM ITGAX MFGE8 FCRL3 MRC2 ACKR3 PLAU PLG ENOX2 NRDC CUBN CR2 ADGRA2 LDLR CSF2RA RNPEP CD86 LPA FCRL4 LY9 IGSF21 TNS1 FCMR | 7.95e-05 | 1111 | 215 | 26 | GO:0009986 |
| GeneOntologyCellularComponent | integrin complex | 3.12e-04 | 32 | 215 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.50e-04 | 59 | 215 | 5 | GO:0098636 | |
| MousePheno | abnormal choroid vasculature morphology | 1.54e-05 | 27 | 168 | 5 | MP:0006237 | |
| MousePheno | pulmonary fibrosis | 3.17e-05 | 51 | 168 | 6 | MP:0006050 | |
| MousePheno | abnormal uvea morphology | MYO10 DCT LYST PLAU STRA6 PLG SEMA3F NECTIN3 CUBN LDLR SLC20A2 LPA | 3.45e-05 | 241 | 168 | 12 | MP:0005197 |
| MousePheno | abnormal optic choroid morphology | 3.55e-05 | 52 | 168 | 6 | MP:0005098 | |
| MousePheno | increased acute phase protein level | 5.76e-05 | 7 | 168 | 3 | MP:0014499 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 1.44e-04 | 2 | 168 | 2 | MP:0009507 | |
| MousePheno | ectropion | 1.44e-04 | 2 | 168 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 1.44e-04 | 2 | 168 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 1.44e-04 | 2 | 168 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 1.44e-04 | 2 | 168 | 2 | MP:0005035 | |
| MousePheno | abnormal professional antigen presenting cell morphology | MAN2B1 AKR1A1 ITGAM ITGAX LYST XYLT1 PTPN6 ACKR3 CLTA TRAPPC9 SUSD4 LIMD1 LRRK1 CR2 LDLR DICER1 CSF2RA TBRG1 SUGCT SLC20A2 FCMR | 1.67e-04 | 726 | 168 | 21 | MP:0008195 |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 1.92e-04 | 10 | 168 | 3 | MP:0003434 | |
| MousePheno | abnormal acute phase protein level | 2.09e-04 | 25 | 168 | 4 | MP:0010211 | |
| MousePheno | abnormal physical strength | TANC2 WDR81 CSMD3 LYST DST ACKR3 PLAU CAMSAP1 DMWD TRAPPC9 NRDC LIMD1 DHX37 FRMPD1 ALG11 LDLR DICER1 NR2F1 CD86 SLC20A2 TPH2 SP5 TNKS2 TNS1 STAG3 VPS13B | 2.31e-04 | 1027 | 168 | 26 | MP:0004262 |
| Domain | - | CEACAM5 HLA-DMB FSTL5 SEMA4C UNC5A FCRL3 IL22RA2 IGSF9 SEMA3F FN1 DSCAM NECTIN3 PTPRU ADGRA2 SEMA3D CSF2RA TIE1 CD86 RIMBP2 FCRL4 LRRN4 LY9 IGSF21 FCMR | 4.36e-07 | 663 | 209 | 24 | 2.60.40.10 |
| Domain | IG | CEACAM5 FSTL5 SEMA4C UNC5A FCRL3 IGSF9 SEMA3F DSCAM NECTIN3 PTPRU ADGRA2 SEMA3D TIE1 CD86 FCRL4 LY9 IGSF21 FCMR | 1.30e-06 | 421 | 209 | 18 | SM00409 |
| Domain | Ig_sub | CEACAM5 FSTL5 SEMA4C UNC5A FCRL3 IGSF9 SEMA3F DSCAM NECTIN3 PTPRU ADGRA2 SEMA3D TIE1 CD86 FCRL4 LY9 IGSF21 FCMR | 1.30e-06 | 421 | 209 | 18 | IPR003599 |
| Domain | Ig-like_fold | CEACAM5 HLA-DMB FSTL5 SEMA4C UNC5A FCRL3 IL22RA2 IGSF9 SEMA3F FN1 DSCAM NECTIN3 PTPRU ADGRA2 SEMA3D CSF2RA TIE1 CD86 RIMBP2 FCRL4 LRRN4 LY9 IGSF21 FCMR | 1.33e-06 | 706 | 209 | 24 | IPR013783 |
| Domain | Sushi_SCR_CCP_dom | 3.27e-06 | 57 | 209 | 7 | IPR000436 | |
| Domain | Ig-like_dom | CEACAM5 HLA-DMB FSTL5 SEMA4C UNC5A FCRL3 IGSF9 SEMA3F DSCAM NECTIN3 PTPRU ADGRA2 SEMA3D TIE1 CD86 FCRL4 LY9 IGSF21 FCMR | 4.04e-06 | 503 | 209 | 19 | IPR007110 |
| Domain | Integrin_alpha | 4.73e-06 | 11 | 209 | 4 | PF00357 | |
| Domain | IG_LIKE | CEACAM5 HLA-DMB FSTL5 SEMA4C UNC5A FCRL3 IGSF9 SEMA3F DSCAM NECTIN3 PTPRU ADGRA2 SEMA3D CD86 FCRL4 LY9 IGSF21 FCMR | 1.10e-05 | 491 | 209 | 18 | PS50835 |
| Domain | Sushi | 2.42e-05 | 52 | 209 | 6 | PF00084 | |
| Domain | Integrin_alpha_C_CS | 2.50e-05 | 16 | 209 | 4 | IPR018184 | |
| Domain | Kringle-like | 2.63e-05 | 32 | 209 | 5 | IPR013806 | |
| Domain | CCP | 3.02e-05 | 54 | 209 | 6 | SM00032 | |
| Domain | SUSHI | 3.72e-05 | 56 | 209 | 6 | PS50923 | |
| Domain | Integrin_alpha-2 | 4.12e-05 | 18 | 209 | 4 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 4.12e-05 | 18 | 209 | 4 | PS00242 | |
| Domain | Integrin_alpha2 | 4.12e-05 | 18 | 209 | 4 | PF08441 | |
| Domain | Integrin_alpha | 4.12e-05 | 18 | 209 | 4 | IPR000413 | |
| Domain | Int_alpha | 5.18e-05 | 19 | 209 | 4 | SM00191 | |
| Domain | Int_alpha_beta-p | 5.18e-05 | 19 | 209 | 4 | IPR013519 | |
| Domain | ig | CEACAM5 HLA-DMB FSTL5 FCRL3 SEMA3F DSCAM TIE1 FCRL4 IGSF21 FCMR | 5.74e-05 | 190 | 209 | 10 | PF00047 |
| Domain | Immunoglobulin | CEACAM5 HLA-DMB FSTL5 FCRL3 SEMA3F DSCAM TIE1 FCRL4 IGSF21 FCMR | 5.74e-05 | 190 | 209 | 10 | IPR013151 |
| Domain | FG_GAP | 9.51e-05 | 22 | 209 | 4 | PS51470 | |
| Domain | FG-GAP | 1.36e-04 | 24 | 209 | 4 | PF01839 | |
| Domain | FG-GAP | 1.36e-04 | 24 | 209 | 4 | IPR013517 | |
| Domain | Integrin_dom | 1.60e-04 | 25 | 209 | 4 | IPR032695 | |
| Domain | Malic_OxRdtase | 3.71e-04 | 3 | 209 | 2 | IPR001891 | |
| Domain | Malic_NAD-bd | 3.71e-04 | 3 | 209 | 2 | IPR012302 | |
| Domain | Malic_N_dom | 3.71e-04 | 3 | 209 | 2 | IPR012301 | |
| Domain | MALIC_ENZYMES | 3.71e-04 | 3 | 209 | 2 | PS00331 | |
| Domain | Malic_M | 3.71e-04 | 3 | 209 | 2 | PF03949 | |
| Domain | Malic_M | 3.71e-04 | 3 | 209 | 2 | SM00919 | |
| Domain | malic | 3.71e-04 | 3 | 209 | 2 | PF00390 | |
| Domain | - | 3.71e-04 | 3 | 209 | 2 | 3.40.50.10380 | |
| Domain | USP7_C2 | 3.71e-04 | 3 | 209 | 2 | PF14533 | |
| Domain | malic | 3.71e-04 | 3 | 209 | 2 | SM01274 | |
| Domain | Malic_enzyme_CS | 3.71e-04 | 3 | 209 | 2 | IPR015884 | |
| Domain | USP_C | 3.71e-04 | 3 | 209 | 2 | IPR029346 | |
| Domain | FN3 | 4.17e-04 | 199 | 209 | 9 | PS50853 | |
| Domain | CNH | 5.69e-04 | 15 | 209 | 3 | PF00780 | |
| Domain | CNH | 5.69e-04 | 15 | 209 | 3 | PS50219 | |
| Domain | CNH_dom | 5.69e-04 | 15 | 209 | 3 | IPR001180 | |
| Domain | FN3_dom | 5.94e-04 | 209 | 209 | 9 | IPR003961 | |
| Domain | MAM_1 | 6.95e-04 | 16 | 209 | 3 | PS00740 | |
| Domain | Ubiquitin_3 | 7.37e-04 | 4 | 209 | 2 | PF14836 | |
| Domain | Ub_USP-typ | 7.37e-04 | 4 | 209 | 2 | IPR028135 | |
| Domain | GPR40-rel_orph | 7.37e-04 | 4 | 209 | 2 | IPR013312 | |
| Domain | Cadherin_tail | 7.53e-04 | 37 | 209 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 7.53e-04 | 37 | 209 | 4 | IPR031904 | |
| Domain | Kringle_CS | 8.37e-04 | 17 | 209 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 8.37e-04 | 17 | 209 | 3 | PS00021 | |
| Domain | MAM | 8.37e-04 | 17 | 209 | 3 | SM00137 | |
| Domain | KR | 8.37e-04 | 17 | 209 | 3 | SM00130 | |
| Domain | Kringle | 8.37e-04 | 17 | 209 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 8.37e-04 | 17 | 209 | 3 | PS50070 | |
| Domain | Kringle | 8.37e-04 | 17 | 209 | 3 | PF00051 | |
| Domain | MAM | 9.96e-04 | 18 | 209 | 3 | PF00629 | |
| Domain | MAM_dom | 9.96e-04 | 18 | 209 | 3 | IPR000998 | |
| Domain | MAM_2 | 9.96e-04 | 18 | 209 | 3 | PS50060 | |
| Domain | LDLR_class-A_CS | 1.02e-03 | 40 | 209 | 4 | IPR023415 | |
| Domain | TRYPSIN_HIS | 1.06e-03 | 103 | 209 | 6 | IPR018114 | |
| Domain | FN3 | 1.16e-03 | 185 | 209 | 8 | SM00060 | |
| Domain | Cadherin_C | 1.22e-03 | 42 | 209 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.22e-03 | 42 | 209 | 4 | PF16492 | |
| Domain | TRYPSIN_SER | 1.23e-03 | 106 | 209 | 6 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.29e-03 | 107 | 209 | 6 | PS00134 | |
| Domain | Semaphorin | 1.37e-03 | 20 | 209 | 3 | IPR027231 | |
| Domain | Ldl_recept_a | 1.59e-03 | 45 | 209 | 4 | PF00057 | |
| Domain | Peptidase_S1A | 1.71e-03 | 113 | 209 | 6 | IPR001314 | |
| Domain | - | 1.72e-03 | 46 | 209 | 4 | 4.10.400.10 | |
| Domain | DUSP | 1.81e-03 | 6 | 209 | 2 | PF06337 | |
| Domain | DUSP | 1.81e-03 | 6 | 209 | 2 | SM00695 | |
| Domain | TRYPSIN_DOM | 1.87e-03 | 115 | 209 | 6 | PS50240 | |
| Domain | LDLRA_1 | 2.02e-03 | 48 | 209 | 4 | PS01209 | |
| Domain | Tryp_SPc | 2.04e-03 | 117 | 209 | 6 | SM00020 | |
| Domain | CUB | 2.18e-03 | 49 | 209 | 4 | PF00431 | |
| Domain | - | 2.18e-03 | 49 | 209 | 4 | 1.20.80.10 | |
| Domain | LDrepeatLR_classA_rpt | 2.18e-03 | 49 | 209 | 4 | IPR002172 | |
| Domain | LDLa | 2.18e-03 | 49 | 209 | 4 | SM00192 | |
| Domain | LDLRA_2 | 2.18e-03 | 49 | 209 | 4 | PS50068 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.35e-03 | 50 | 209 | 4 | IPR014352 | |
| Domain | CUB | 2.35e-03 | 50 | 209 | 4 | SM00042 | |
| Domain | fn3 | 2.35e-03 | 162 | 209 | 7 | PF00041 | |
| Domain | Trypsin_dom | 2.42e-03 | 121 | 209 | 6 | IPR001254 | |
| Domain | Trypsin | 2.42e-03 | 121 | 209 | 6 | PF00089 | |
| Domain | DUSP | 2.52e-03 | 7 | 209 | 2 | PS51283 | |
| Domain | - | 2.52e-03 | 7 | 209 | 2 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 2.52e-03 | 7 | 209 | 2 | IPR006615 | |
| Domain | Peptidase_S1_PA | 2.62e-03 | 123 | 209 | 6 | IPR009003 | |
| Domain | - | 2.71e-03 | 52 | 209 | 4 | 2.60.120.290 | |
| Domain | CUB | 2.91e-03 | 53 | 209 | 4 | PS01180 | |
| Domain | Acyl-CoA-binding_protein | 3.34e-03 | 8 | 209 | 2 | IPR000582 | |
| Domain | VWA | 3.55e-03 | 56 | 209 | 4 | PF00092 | |
| Domain | - | 3.74e-03 | 92 | 209 | 5 | 3.90.190.10 | |
| Domain | CUB_dom | 3.79e-03 | 57 | 209 | 4 | IPR000859 | |
| Domain | LRR_TYP | 3.84e-03 | 177 | 209 | 7 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.84e-03 | 177 | 209 | 7 | IPR003591 | |
| Domain | MYTH4 | 4.26e-03 | 9 | 209 | 2 | PS51016 | |
| Domain | BEACH | 4.26e-03 | 9 | 209 | 2 | PS50197 | |
| Domain | Beach | 4.26e-03 | 9 | 209 | 2 | PF02138 | |
| Domain | - | 4.26e-03 | 9 | 209 | 2 | 1.10.1540.10 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 MAN2B1 MYO10 INPPL1 FHIP1B TTC3 LYST SLC52A3 PRR12 DST MTMR3 USP7 HERC1 CAMSAP1 DMWD TRAPPC9 ATMIN SEMA3F PNPLA2 SZT2 RHOT2 LRRK1 REV3L ADGRA2 LDLR TRIB3 DHX34 | 1.54e-09 | 1105 | 216 | 27 | 35748872 |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 15743790 | ||
| Pubmed | Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. | 2.36e-07 | 3 | 216 | 3 | 11929773 | |
| Pubmed | Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. | 2.36e-07 | 3 | 216 | 3 | 12431907 | |
| Pubmed | Lactational competence and involution of the mouse mammary gland require plasminogen. | 2.36e-07 | 3 | 216 | 3 | 11003846 | |
| Pubmed | MYO10 FSTL5 FHIP1B CSMD3 SNX13 PLEKHH1 UNC5A MTMR3 HERC3 USP15 ATMIN FRMPD1 RIMBP2 VPS13B | 3.06e-07 | 407 | 216 | 14 | 12693553 | |
| Pubmed | A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. | 4.61e-07 | 11 | 216 | 4 | 26647393 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 9.09e-07 | 211 | 216 | 10 | 24097068 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 12100475 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 19210287 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 12911578 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 15161662 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 21704601 | ||
| Pubmed | Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator. | 9.41e-07 | 4 | 216 | 3 | 16554301 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 18042398 | ||
| Pubmed | Sp5 induces the expression of Nanog to maintain mouse embryonic stem cell self-renewal. | 9.41e-07 | 4 | 216 | 3 | 28961274 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 11404420 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 19286661 | ||
| Pubmed | Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice. | 9.41e-07 | 4 | 216 | 3 | 21931850 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 21326869 | ||
| Pubmed | Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. | 9.41e-07 | 4 | 216 | 3 | 16763560 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 28336948 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 14769799 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 12657615 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 37781399 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 12875972 | ||
| Pubmed | The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. | 2.34e-06 | 5 | 216 | 3 | 11818362 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 24466030 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 15210787 | ||
| Pubmed | CD11c regulates hematopoietic stem and progenitor cells under stress. | 2.34e-06 | 5 | 216 | 3 | 33351105 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 18957535 | ||
| Pubmed | Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation. | 2.34e-06 | 5 | 216 | 3 | 21273553 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 11306532 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 10880388 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 31819012 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 19147818 | ||
| Pubmed | Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. | 4.66e-06 | 6 | 216 | 3 | 15841177 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 10318667 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 30082873 | ||
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 15585877 | ||
| Pubmed | CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets. | 4.66e-06 | 6 | 216 | 3 | 33543002 | |
| Pubmed | 7.97e-06 | 21 | 216 | 4 | 16079250 | ||
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 7.97e-06 | 21 | 216 | 4 | 36240771 | |
| Pubmed | 8.46e-06 | 162 | 216 | 8 | 25826454 | ||
| Pubmed | 1.17e-05 | 23 | 216 | 4 | 39226900 | ||
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 9438420 | ||
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 25893677 | ||
| Pubmed | Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. | 1.29e-05 | 8 | 216 | 3 | 18097035 | |
| Pubmed | FHIP1B DST MRC2 TGFBRAP1 WDR20 USP32 TBC1D12 ACBD3 TRAPPC9 DHX37 | 1.31e-05 | 285 | 216 | 10 | 34369648 | |
| Pubmed | A secreted protein microarray platform for extracellular protein interaction discovery. | 1.64e-05 | 51 | 216 | 5 | 21982860 | |
| Pubmed | 1.81e-05 | 52 | 216 | 5 | 26633812 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 2.27e-05 | 27 | 216 | 4 | 31541017 | |
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 20889973 | ||
| Pubmed | 3.76e-05 | 11 | 216 | 3 | 18083160 | ||
| Pubmed | 3.76e-05 | 11 | 216 | 3 | 23981064 | ||
| Pubmed | HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG. | 3.84e-05 | 2 | 216 | 2 | 32088087 | |
| Pubmed | Association of ITGAX and ITGAM gene polymorphisms with susceptibility to IgA nephropathy. | 3.84e-05 | 2 | 216 | 2 | 31227791 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 15539558 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 8068691 | ||
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 3.84e-05 | 2 | 216 | 2 | 7705657 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 23041318 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 6216475 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 22506074 | ||
| Pubmed | The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. | 3.84e-05 | 2 | 216 | 2 | 4226004 | |
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 3.84e-05 | 2 | 216 | 2 | 15456492 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 8573344 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 22268142 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 24748202 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 23702659 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 36362376 | ||
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 3.84e-05 | 2 | 216 | 2 | 22079981 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 3.84e-05 | 2 | 216 | 2 | 9490683 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 16481742 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 18983515 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 8093859 | ||
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 3.84e-05 | 2 | 216 | 2 | 19415763 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 11848464 | ||
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 3.84e-05 | 2 | 216 | 2 | 21239499 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 9884337 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 19417080 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 23110765 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 27234908 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 7904248 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 511162 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 25714599 | ||
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 3.84e-05 | 2 | 216 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 3.84e-05 | 2 | 216 | 2 | 10885855 | |
| Pubmed | Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. | 3.84e-05 | 2 | 216 | 2 | 17420351 | |
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 3.84e-05 | 2 | 216 | 2 | 12559391 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 37298730 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 23024797 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 37019194 | ||
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 3.84e-05 | 2 | 216 | 2 | 23555246 | |
| Pubmed | Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. | 3.84e-05 | 2 | 216 | 2 | 15175354 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 30254165 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 38328826 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 38040866 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 3.84e-05 | 2 | 216 | 2 | 18420257 | |
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 3.84e-05 | 2 | 216 | 2 | 18566672 | |
| GeneFamily | Immunoglobulin like domain containing | CEACAM5 SEMA4C FCRL3 IGSF9 SEMA3F DSCAM NECTIN3 ADGRA2 TIE1 CD86 FCRL4 LY9 IGSF21 FCMR | 1.55e-09 | 193 | 158 | 14 | 594 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.24e-07 | 57 | 158 | 7 | 1179 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.56e-05 | 18 | 158 | 4 | 1160 | |
| GeneFamily | Neuroblastoma breakpoint family | 4.37e-05 | 23 | 158 | 4 | 662 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | CEACAM5 ITGAD ITGAE ITGAM ITGAX FCRL3 MRC2 NECTIN3 CR2 CSF2RA CD86 FCRL4 LY9 | 4.38e-05 | 394 | 158 | 13 | 471 |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 6.69e-04 | 20 | 158 | 3 | 736 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 7.46e-04 | 5 | 158 | 2 | 655 | |
| GeneFamily | HOXL subclass homeoboxes | 1.10e-03 | 52 | 158 | 4 | 518 | |
| GeneFamily | Clustered protocadherins | 2.37e-03 | 64 | 158 | 4 | 20 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.62e-03 | 9 | 158 | 2 | 1230 | |
| GeneFamily | Fibronectin type III domain containing | 2.84e-03 | 160 | 158 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.93e-03 | 161 | 158 | 6 | 593 | |
| GeneFamily | Complement system|Sushi domain containing | 3.78e-03 | 36 | 158 | 3 | 492 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | AFAP1L1 UNC5A DST HOXD8 RASGRP3 ADGRA2 NR2F1 SEMA3D SNCAIP TIE1 LOX | 1.98e-09 | 186 | 216 | 11 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | AFAP1L1 UNC5A HOXD8 RASGRP3 ADAMTS20 HIF3A NR2F1 SEMA3D SNCAIP TIE1 LOX | 1.98e-09 | 186 | 216 | 11 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue | HLA-DMB ACP5 ITGAX PTPN6 FCRL3 RASGRP3 POU2AF1 LRRK1 CD86 FCRL4 FCMR | 2.62e-09 | 191 | 216 | 11 | c3ca8077da8594fb493e47ac4dfbbd20bfc14b37 |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | AFAP1L1 UNC5A DST HOXD8 RASGRP3 HIF3A NR2F1 SEMA3D SNCAIP TIE1 | 1.78e-08 | 178 | 216 | 10 | ad3de3e03a401dac64431a541899445262246347 |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | UNC5A HOXD8 RASGRP3 ADAMTS20 HIF3A NR2F1 SEMA3D SNCAIP TIE1 LOX | 2.09e-08 | 181 | 216 | 10 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | AFAP1L1 UNC5A DST HOXD8 RASGRP3 NR2F1 SEMA3D SNCAIP TIE1 LOX | 2.20e-08 | 182 | 216 | 10 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.57e-08 | 185 | 216 | 10 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ELAPOR2 UNC5A RASGRP3 FN1 ADGRA2 NR2F1 SEMA3D SNCAIP TIE1 LOX | 2.99e-08 | 188 | 216 | 10 | 26915db8863f4115b46a81982e187322e21600fd |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ELAPOR2 UNC5A RASGRP3 FN1 ADGRA2 NR2F1 SEMA3D SNCAIP TIE1 LOX | 2.99e-08 | 188 | 216 | 10 | 61ee7b152745164293d8a44ef91ee2393efbdca5 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ELAPOR2 UNC5A RASGRP3 FN1 ADGRA2 NR2F1 SEMA3D SNCAIP TIE1 LOX | 2.99e-08 | 188 | 216 | 10 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.73e-08 | 161 | 216 | 9 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.73e-08 | 161 | 216 | 9 | c53c461fc721a7960cef86662f49e2a495520701 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-07 | 162 | 216 | 9 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-07 | 168 | 216 | 9 | 784ce773521e5d74570f45120e56d112bc76ff49 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-07 | 170 | 216 | 9 | 7a4ed69c807c3761210776e8fe6680d1bd892e82 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-07 | 171 | 216 | 9 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | COVID-19_Moderate-B_intermediate|World / disease group, cell group and cell class | 2.52e-07 | 180 | 216 | 9 | bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.32e-07 | 186 | 216 | 9 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-07 | 186 | 216 | 9 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-07 | 186 | 216 | 9 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-07 | 186 | 216 | 9 | b5e094850ac3785775393cd78a939b02339732b0 | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|tumor_Lung / Location, Cell class and cell subclass | 3.47e-07 | 187 | 216 | 9 | 87ecdc5f24aced95a37e653429f0fc493ff4aa3e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-07 | 188 | 216 | 9 | 7b56c680e9f1851cb961b0f8faeeb987685ae36d | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.80e-07 | 189 | 216 | 9 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 3.80e-07 | 189 | 216 | 9 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-07 | 190 | 216 | 9 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.97e-07 | 190 | 216 | 9 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-07 | 190 | 216 | 9 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-07 | 190 | 216 | 9 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.34e-07 | 192 | 216 | 9 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.34e-07 | 192 | 216 | 9 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.34e-07 | 192 | 216 | 9 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue | 4.73e-07 | 194 | 216 | 9 | b57ae94a092b58623a244a258b4659a3864542c7 | |
| ToppCell | distal-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.94e-07 | 195 | 216 | 9 | 8e0f67a67af3bc0b16f48a621f74540f136383b7 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.38e-07 | 197 | 216 | 9 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-07 | 198 | 216 | 9 | 824461cf44098440ba8bc0df96735423ac65bda1 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.85e-07 | 199 | 216 | 9 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.85e-07 | 199 | 216 | 9 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-07 | 199 | 216 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-07 | 199 | 216 | 9 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.85e-07 | 199 | 216 | 9 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-06 | 162 | 216 | 8 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 162 | 216 | 8 | 1fda21a303a08aff6f97819cd8766cd18784d8bc | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 162 | 216 | 8 | fc313fb2c55957faa8c9ca4023b3fce63527c267 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 162 | 216 | 8 | 002fac3c5c3030950f9eb9e887d59902586d8452 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 162 | 216 | 8 | 08b7f06580d516307516d5475a5dae0fa040f1a4 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 165 | 216 | 8 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 165 | 216 | 8 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 168 | 216 | 8 | 08eb1284f9b8bd3e0e4b21bfc2bbee01d35a0bd7 | |
| ToppCell | droplet-Fat-Gat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 170 | 216 | 8 | 5185187ecf26b4c9eaa0c01ad52697ab8d075cc7 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 172 | 216 | 8 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 172 | 216 | 8 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 172 | 216 | 8 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 172 | 216 | 8 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 173 | 216 | 8 | 71c90c57225e452c73bf7bea46b454c472bf5f76 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-06 | 174 | 216 | 8 | fde40c5d51f5380088360dc5a583eb04e518deb6 | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-06 | 176 | 216 | 8 | 318dc722b95e269002fb01a0feb91c0c8539e150 | |
| ToppCell | facs-Trachea-24m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-06 | 176 | 216 | 8 | f6891006d816309edabe75b2abf60675f2958e55 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 177 | 216 | 8 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 177 | 216 | 8 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-06 | 177 | 216 | 8 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 177 | 216 | 8 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-06 | 178 | 216 | 8 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-06 | 179 | 216 | 8 | 9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.74e-06 | 179 | 216 | 8 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 180 | 216 | 8 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 180 | 216 | 8 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-06 | 180 | 216 | 8 | eedb6d89680f968167afb1dcd132c9de9096b50f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 180 | 216 | 8 | 14ca8875af7cceead88fec147a4c0ef4d5a41f26 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 182 | 216 | 8 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 182 | 216 | 8 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-06 | 182 | 216 | 8 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Lymphocytic|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 183 | 216 | 8 | eb2f37c3d6d0502fb9eb512537fc2a002a1b92ed | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 183 | 216 | 8 | 20f7b6ec2462032eda957a893ca76d5a5a01333d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 183 | 216 | 8 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-06 | 183 | 216 | 8 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 183 | 216 | 8 | 56038766980a4186ecd3b4a327a91c12979d2364 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-06 | 183 | 216 | 8 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-06 | 184 | 216 | 8 | 95cf125127658c4c04445c61809d1aed21ee1f83 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 184 | 216 | 8 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 184 | 216 | 8 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-06 | 184 | 216 | 8 | efcd643324ccd212350dc6a27f40efbb666d557b | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 184 | 216 | 8 | 5cf7447faaec99fc37dfa8e92ff72cc2c7c05951 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 184 | 216 | 8 | 7126261a453c7e2f3f005016873b6adeb51e46f8 | |
| ToppCell | (1)_B_CD27neg|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.64e-06 | 186 | 216 | 8 | 646389147189760e9493c4f50f9583959ef0ee26 | |
| ToppCell | (1)_B_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.64e-06 | 186 | 216 | 8 | fe0f8e99ca766e004c351835fdbc2dc888dceb62 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-06 | 187 | 216 | 8 | 57f9c9162694c184a8fd6634ee0fad511ca71c9e | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-06 | 187 | 216 | 8 | 6ce6d3678026101c4397320430433c9f05740883 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-06 | 188 | 216 | 8 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.94e-06 | 188 | 216 | 8 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.94e-06 | 188 | 216 | 8 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.94e-06 | 188 | 216 | 8 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.94e-06 | 188 | 216 | 8 | 064a66cbca5648371d6360cfcb3965845a81c65f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-06 | 188 | 216 | 8 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | 367C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-06 | 190 | 216 | 8 | c34facacdbd093075d7f330168706e2cf525f5fc | |
| ToppCell | 367C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-06 | 190 | 216 | 8 | 3a0542bccf48f7b865f84363e1025072189275c4 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-06 | 190 | 216 | 8 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | critical-Lymphoid-B_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.42e-06 | 191 | 216 | 8 | 0716cfaeb11d9c90c18fa8f9d50c9c6fb5182848 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Follicular_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.42e-06 | 191 | 216 | 8 | 06edf2e9b50ea20060648d41fa42ee16086fdf42 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.42e-06 | 191 | 216 | 8 | ce0217d375af6b19252a45340b72241ea7b204d4 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 3.37e-06 | 5 | 207 | 3 | EFO_0003884, EFO_0009324 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.09e-05 | 71 | 207 | 6 | EFO_0007878, EFO_0007979 | |
| Disease | mental development measurement | 2.65e-05 | 25 | 207 | 4 | EFO_0008230 | |
| Disease | IGA glomerulonephritis | 5.48e-05 | 58 | 207 | 5 | EFO_0004194 | |
| Disease | Malignant neoplasm of breast | KLK10 CATSPERE TTC3 SORCS1 HOXA4 MFGE8 LMF2 FCRL3 BRCA2 OTOGL MTMR3 NHS FN1 PCDHGB6 FRMPD1 CUBN MAMDC4 NR2F1 TNS1 VPS13B | 7.47e-05 | 1074 | 207 | 20 | C0006142 |
| Disease | Alcohol abuse | 1.10e-04 | 67 | 207 | 5 | C0085762 | |
| Disease | Fc receptor-like protein 4 measurement | 2.91e-04 | 4 | 207 | 2 | EFO_0801599 | |
| Disease | Fc receptor-like protein 3 measurement | 2.91e-04 | 4 | 207 | 2 | EFO_0008127 | |
| Disease | cortical thickness | KLHL24 RNLS TM7SF3 ME2 AFAP1L1 CEP120 LRRIQ1 ACKR3 ANGPT4 MTMR3 ADAMTS20 IGSF9 USP15 AGBL1 ADGRA2 STPG2 PCDHGB4 SSH2 TNS1 | 3.40e-04 | 1113 | 207 | 19 | EFO_0004840 |
| Disease | serum homoarginine measurement | 3.55e-04 | 20 | 207 | 3 | EFO_0005421 | |
| Disease | Deep Vein Thrombosis | 4.12e-04 | 21 | 207 | 3 | C0149871 | |
| Disease | Venous Thrombosis | 4.12e-04 | 21 | 207 | 3 | C0042487 | |
| Disease | plasma plasminogen measurement | 4.83e-04 | 5 | 207 | 2 | EFO_0006309 | |
| Disease | Joubert syndrome with ocular defect | 4.83e-04 | 5 | 207 | 2 | C4274118 | |
| Disease | Coronary heart disease | 6.18e-04 | 24 | 207 | 3 | C0010068 | |
| Disease | cholesterol to total lipids in large LDL percentage | 6.50e-04 | 56 | 207 | 4 | EFO_0022235 | |
| Disease | Chanarin-Dorfman syndrome (implicated_via_orthology) | 7.21e-04 | 6 | 207 | 2 | DOID:0050729 (implicated_via_orthology) | |
| Disease | angiostatin measurement | 7.21e-04 | 6 | 207 | 2 | EFO_0008024 | |
| Disease | coronary artery disease | MYH11 ZBTB20 RNLS SNX13 CEP120 PLG PARP12 FN1 DSCAM RNASE12 ZC2HC1C PTPRU ANKRD55 LDLR CCT6A SLC15A1 LOX LPA TNS1 | 7.95e-04 | 1194 | 207 | 19 | EFO_0001645 |
| Disease | Spondylometaphyseal dysplasia | 1.00e-03 | 7 | 207 | 2 | cv:C4759767 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 1.00e-03 | 7 | 207 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Type II Collagenopathies | 1.00e-03 | 7 | 207 | 2 | cv:CN043672 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 1.00e-03 | 7 | 207 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.14e-03 | 111 | 207 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.16e-03 | 166 | 207 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 1.20e-03 | 30 | 207 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | cortical surface area measurement | TANC2 RNLS RETSAT SNX13 AFAP1L1 CEP120 LRRIQ1 ACKR3 ADAMTS20 IGSF9 MAP4K4 AGBL1 ZAN NECTIN3 ADGRA2 NR2F1 STPG2 SEMA3D SSH2 TNS1 | 1.32e-03 | 1345 | 207 | 20 | EFO_0010736 |
| Disease | X-11793--oxidized bilirubin measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0802740 | |
| Disease | Congenital Hydrocephalus | 1.33e-03 | 8 | 207 | 2 | C0020256 | |
| Disease | X-16946 measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0800766 | |
| Disease | total blood protein measurement | RNLS SNX13 NYNRIN RASGRP3 MAP4K3 POU2AF1 LRRK1 ANKRD55 CD86 HYDIN | 1.35e-03 | 449 | 207 | 10 | EFO_0004536 |
| Disease | clopidogrel metabolite measurement | 1.59e-03 | 33 | 207 | 3 | EFO_0007966 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 1.61e-03 | 120 | 207 | 5 | EFO_0004611, EFO_0004639 | |
| Disease | hypertension (is_implicated_in) | 1.67e-03 | 121 | 207 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | testosterone measurement | ZBTB20 MAP1A WDR81 CSMD3 DCT CEP120 TGFBRAP1 NYNRIN USP7 ZAN NRDC DSCAM UGT1A5 RNASE12 SEMA3D SUGCT SLC20A2 RIMBP2 TNKS2 | 1.70e-03 | 1275 | 207 | 19 | EFO_0004908 |
| Disease | X-11442 measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.71e-03 | 9 | 207 | 2 | EFO_0004570, GO_0009410 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.73e-03 | 34 | 207 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | Nephroblastoma | 2.05e-03 | 36 | 207 | 3 | C0027708 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 2.12e-03 | 10 | 207 | 2 | DOID:7693 (is_marker_for) | |
| Disease | bilirubin measurement, response to tenofovir | 2.12e-03 | 10 | 207 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 2.12e-03 | 10 | 207 | 2 | EFO_0800816 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.12e-03 | 10 | 207 | 2 | cv:C4707243 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.12e-03 | 10 | 207 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 2.12e-03 | 10 | 207 | 2 | EFO_0800867 | |
| Disease | metabolite measurement | ZBTB20 AKR1A1 SORCS1 DSCAM UGT1A5 REV3L UGT1A3 AGXT2 RNPEP SUGCT RIMBP2 | 2.12e-03 | 560 | 207 | 11 | EFO_0004725 |
| Disease | atherosclerosis (is_marker_for) | 2.22e-03 | 37 | 207 | 3 | DOID:1936 (is_marker_for) | |
| Disease | histidine betaine (hercynine) measurement | 2.58e-03 | 11 | 207 | 2 | EFO_0800972 | |
| Disease | thoracic aortic aneurysm (is_implicated_in) | 2.58e-03 | 11 | 207 | 2 | DOID:14004 (is_implicated_in) | |
| Disease | Aortic Valve Insufficiency | 2.58e-03 | 11 | 207 | 2 | C0003504 | |
| Disease | X-21796 measurement | 2.58e-03 | 11 | 207 | 2 | EFO_0800825 | |
| Disease | interleukin-6 measurement, response to stimulus | 2.58e-03 | 11 | 207 | 2 | EFO_0004810, GO_0050896 | |
| Disease | colon cancer (implicated_via_orthology) | 2.58e-03 | 11 | 207 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | insomnia, bilirubin measurement | 2.58e-03 | 11 | 207 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.58e-03 | 11 | 207 | 2 | EFO_0010219 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.78e-03 | 40 | 207 | 3 | EFO_0004746 | |
| Disease | vital capacity | DIS3L2 SNX13 AFAP1L1 DST CEP120 LRRIQ1 MRC2 ANGPT4 MTMR3 FN1 MYH7B FRMPD1 OMD TBX18 SEMA3D SUGCT LOX TNS1 | 2.86e-03 | 1236 | 207 | 18 | EFO_0004312 |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 2.86e-03 | 137 | 207 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | Lenticulostriate Disorders | 3.09e-03 | 12 | 207 | 2 | C0750951 | |
| Disease | Extrapyramidal Disorders | 3.09e-03 | 12 | 207 | 2 | C0015371 | |
| Disease | p-cresol glucuronide measurement | 3.09e-03 | 12 | 207 | 2 | EFO_0800079 | |
| Disease | Dental enamel hypoplasia | 3.09e-03 | 12 | 207 | 2 | EFO_1001304 | |
| Disease | biliverdin measurement | 3.09e-03 | 12 | 207 | 2 | EFO_0021033 | |
| Disease | Basal Ganglia Diseases | 3.09e-03 | 12 | 207 | 2 | C0004782 | |
| Disease | Thromboembolism | 3.09e-03 | 12 | 207 | 2 | C0040038 | |
| Disease | aortic stenosis, aortic valve calcification | 3.19e-03 | 42 | 207 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.42e-03 | 43 | 207 | 3 | EFO_0022290 | |
| Disease | chronic obstructive pulmonary disease | AKR1A1 ME3 AFAP1L1 MRC2 RASGRP3 MTMR3 DMWD LOX TRIM62 CEP41 SSH2 TNS1 | 3.57e-03 | 688 | 207 | 12 | EFO_0000341 |
| Disease | IGFBP-1 measurement | 3.63e-03 | 13 | 207 | 2 | EFO_0005118 | |
| Disease | retinol dehydrogenase 16 measurement | 3.63e-03 | 13 | 207 | 2 | EFO_0802007 | |
| Disease | neuroimaging measurement | RNLS AFAP1L1 LRRIQ1 ACKR3 RASGRP3 SLC27A1 ADAMTS20 IGSF9 AGBL1 SZT2 RNASE12 REV3L STPG2 SEMA3D SSH2 TNS1 | 3.74e-03 | 1069 | 207 | 16 | EFO_0004346 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.91e-03 | 91 | 207 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | end stage renal disease (is_marker_for) | 4.14e-03 | 46 | 207 | 3 | DOID:783 (is_marker_for) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.14e-03 | 46 | 207 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | nephroblastoma (is_implicated_in) | 4.22e-03 | 14 | 207 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | trimethylamine-N-oxide measurement | 4.22e-03 | 14 | 207 | 2 | EFO_0010541 | |
| Disease | systemic lupus erythematosus | HLA-DMB CDHR5 ITGAM ITGAX LYST FCRL3 RASGRP3 PLAU LRRK1 SEZ6L2 ANKRD55 AGXT2 CD86 | 4.41e-03 | 799 | 207 | 13 | MONDO_0007915 |
| Disease | creatinine measurement | RNLS AKR1A1 SLC52A3 USP32 MTMR3 CFAP70 DSCAM MYH7B POU2AF1 CUBN INTS8 LDLR LPA PCDHGB4 IGSF21 | 4.63e-03 | 995 | 207 | 15 | EFO_0004518 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 4.72e-03 | 220 | 207 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | non-high density lipoprotein cholesterol measurement | WDR81 BRCA2 NYNRIN OSBPL9 FN1 NRDC UGT1A5 RNASE12 LDLR UGT1A3 LPA HYDIN | 4.73e-03 | 713 | 207 | 12 | EFO_0005689 |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 4.84e-03 | 15 | 207 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | response to statin, LDL cholesterol change measurement | 4.84e-03 | 15 | 207 | 2 | EFO_0007804, GO_0036273 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 4.84e-03 | 15 | 207 | 2 | OBA_2045067 | |
| Disease | Tourette syndrome | 5.23e-03 | 50 | 207 | 3 | EFO_0004895 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 5.72e-03 | 229 | 207 | 6 | EFO_0004639, EFO_0008317 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEIAPHIIYCSITGY | 156 | Q9HAC7 | |
| PYHDVLHSILGAYTC | 566 | O60347 | |
| PDCLGHAGLVYEYTL | 341 | P40227 | |
| SYICHAFSAPYASLA | 221 | P35503 | |
| AYHGCSPYTLGLTNV | 196 | Q9BYV1 | |
| CQVGSYVHYPTISTD | 191 | Q2TAA5 | |
| SGPSCELHLAYYLQS | 556 | Q6UXC1 | |
| SRPANHCVYFYGDEI | 381 | P04003 | |
| KLCPVYFHSNGSEYI | 346 | Q6ZRH7 | |
| YTQPFSHYGQALCVS | 111 | Q9H4A4 | |
| YTGHPLEIAVFLNYC | 396 | Q5SY80 | |
| RYSCVTGYILDGHPQ | 201 | Q7Z407 | |
| NYSVGHNCVYSIAVP | 1781 | Q7Z407 | |
| VESGIHPVYFCSTHY | 1116 | Q96NH3 | |
| HYIATCVFLGPDYQV | 1176 | Q96NH3 | |
| PGDYSHCLYTNDITR | 411 | Q96PE1 | |
| YYRPGVNLSLSCHAA | 426 | P06731 | |
| YYPHVGVTAAAAAAA | 286 | Q03828 | |
| LPAIRQSHAGGYYCT | 346 | Q96PJ5 | |
| QCHIVGAYSYPIATL | 186 | Q9BYV8 | |
| YIYHCNAQNPSGETA | 241 | Q8TB40 | |
| RDYVESHYQLQLCPG | 216 | O95376 | |
| INESTPLAYALYCGH | 296 | Q3KP44 | |
| VYINLTCSSIHGYPE | 151 | P42081 | |
| YVCIQAQYHGAVPTG | 246 | Q9HBB8 | |
| LFCTYPDAHEGRLSY | 1331 | Q9UPY3 | |
| DHETGLPQGCHIYEY | 561 | Q8IYB7 | |
| GAALLAVIHYYCPEQ | 251 | Q5T5Y3 | |
| GHLYLYNVSHPCASA | 236 | Q09019 | |
| EVLCVGNLYNPDVHY | 821 | P59510 | |
| AVTFPHSEDVCYLAY | 716 | Q96MI9 | |
| VLHECNSPYIVGFYG | 121 | P36507 | |
| YALTNGDPLNGHCYL | 171 | P10589 | |
| AALHYYLQAGAVCSD | 851 | Q75QN2 | |
| PHYYEQTRGGQVSVC | 481 | P20702 | |
| PRTNNIELHYCTGAY | 321 | Q9NVM9 | |
| YHEVHYILLDPSCSG | 296 | Q96P11 | |
| GCPANRIHTYVYEFI | 56 | Q86WS3 | |
| GTLPYSYNLCIAHTG | 746 | Q9Y5F9 | |
| LPYSYNLCVAHTGKT | 746 | Q9UN71 | |
| CLDYDEHYILTFPNG | 546 | Q96SU4 | |
| TVGRYIADHSYFCPV | 246 | Q8N612 | |
| YYVGVASCLREHAPF | 21 | Q96AD5 | |
| PYTGHKYLCGALQTS | 681 | Q8IVH8 | |
| SGSVYDIYLPTHIQC | 1101 | O95819 | |
| LQAVATLSFPYCGAH | 156 | Q8NG77 | |
| CTYAAITAQYHGGPL | 311 | Q9HBL6 | |
| AIYCVVGSHEDPAVY | 296 | P46095 | |
| VYVDLAYIPNHCSGK | 2691 | P78559 | |
| PSCLTHGDYYDNLSL | 171 | Q9UGP4 | |
| AAAGEAINPTYYDCH | 21 | P13378 | |
| EAQYVRLYPTSCHTA | 201 | Q08431 | |
| HGAYFCSYILLDSPD | 216 | Q38SD2 | |
| YQHYEDASCGLLAGL | 4046 | Q03001 | |
| HPCYLSGYQTTLALG | 271 | Q5MY95 | |
| ASGEEYLPVAHTCYN | 1006 | Q15034 | |
| HPVYGYSAAAAAAAL | 161 | P50219 | |
| SCSGPLYLAAVYGHL | 171 | Q8WXK4 | |
| HVHPFGASIEYICSY | 546 | Q16206 | |
| YGNLSDQPYGTQSCH | 921 | Q15751 | |
| HARCYEVGQALYGAP | 591 | Q96HB5 | |
| TCSLSYIAGAPRYKH | 471 | P38570 | |
| NPYDYHFCSQGVITV | 351 | A7E2Y1 | |
| CSSHLSVVGLYYGAA | 241 | Q96R27 | |
| LQAVATLSFPYCGAH | 156 | A6NH00 | |
| SYCYHPDVIQLACSD | 186 | A6NGY5 | |
| EGTLPYSYNLCIASH | 741 | Q9Y5G3 | |
| IHSNISVSYLEGCYP | 1151 | Q02817 | |
| CLYLNIYAPAHADTG | 121 | Q6NT32 | |
| SLYSSYHQGCLVNPT | 176 | Q9H9S0 | |
| STPENYHYLNQSGCV | 281 | Q9HD67 | |
| DLCALPYHEVYTIQG | 166 | Q9UBG0 | |
| DCHEEVYAGSHQYPG | 486 | Q9H3P7 | |
| LTPHSSYCVVAEIYQ | 231 | Q969J5 | |
| CYGVAIFTYIQPHSS | 251 | Q13607 | |
| QGTLPYSYNLCVAHT | 741 | Q9Y5G0 | |
| YNVSHVVGYICGESP | 241 | O15529 | |
| ECPPDTYLSIHQVYG | 636 | A8MWY0 | |
| YVLGRHAPCEGLSNY | 676 | Q96JM4 | |
| KCVPQSLAYTHLGGY | 646 | Q8N475 | |
| PLGYNVTRCHTYTVS | 406 | Q92729 | |
| AYLAYCTPGSDGQAA | 411 | Q9H0J9 | |
| TCGAHLLSVSLYYGP | 256 | Q8NGV6 | |
| HYYEQTRGGQVSVCP | 481 | Q13349 | |
| PYSAVALVAFAGYAH | 311 | Q9UHM6 | |
| TEYVPHEAVSCPYSA | 106 | Q16633 | |
| SYRSPDVGYVHDVNC | 486 | O60494 | |
| VPSTSCSHDYLAIYD | 3086 | O60494 | |
| GCPYASRTALQSHIY | 196 | O43313 | |
| YGDTYTCVVEHTGAP | 186 | P28068 | |
| NGPYECHVGIYDRAT | 111 | Q96ID5 | |
| GSAHCYEAILYNKGS | 476 | Q4G0P3 | |
| CYNGHYSDSILTFDP | 551 | Q96M94 | |
| PVSYHGCVTIHRYNE | 581 | Q6TFL4 | |
| YSHNDIVYVDCNPGF | 806 | P20023 | |
| VPSACSHKQLYTYGV | 2531 | P51587 | |
| GYHQIGPAEYCTDSF | 176 | Q8N960 | |
| CLYPAVSAVYGNTEV | 261 | P0C2W1 | |
| FSNIEHYTGSCYQSP | 111 | Q8N6M3 | |
| HYTGSCYQSPALEGV | 116 | Q8N6M3 | |
| SCFDPYTVSHYAVGD | 2296 | P02751 | |
| GPSCEYYLVLAQTHI | 926 | Q5T0N1 | |
| CSYLVAGTEKHPGYA | 186 | A0A1W2PPK0 | |
| GSHADYYSLCSSVSP | 701 | Q5SYB0 | |
| YNVSHVVGYICGESP | 241 | O14843 | |
| QEPYYQAAAAGALTC | 196 | Q9NZP8 | |
| GYDTHCYILNLAIAD | 76 | P25106 | |
| ACGLSNLNGVYYHAP | 456 | Q9Y264 | |
| SPVVQDCYHGDGRSY | 1496 | P08519 | |
| QEAFYLYACGPNHTS | 1681 | Q99698 | |
| YYCAADNVHSPILST | 356 | Q96P31 | |
| DAGPYHAYVCSEASS | 331 | Q9HBG7 | |
| GSSVHVLYSTPACYL | 346 | O00754 | |
| TAHTQGLSPGCYDTY | 341 | P28300 | |
| VYTPTVGLACSQYGH | 111 | P23368 | |
| VYTPTVGLACQHYGL | 136 | Q16798 | |
| PPAYSAVNYHCNEVD | 206 | Q92904 | |
| NQYVLEEGHYPCLSA | 1466 | Q9Y4K1 | |
| PQYLLAAGFSHVACT | 196 | Q14147 | |
| EPGHCYRLYSSAVFG | 676 | Q8IY37 | |
| GTNKEYGHYSSPSLC | 321 | Q92681 | |
| YHYSPTEGFVLVTCD | 121 | Q5GAN4 | |
| YHTFVALCYLTPILG | 56 | P46059 | |
| YTCYTAAICGLPVHA | 386 | Q08357 | |
| AAALYPAHGAADTAY | 86 | Q00056 | |
| PYYIQDSGTHVGCHL | 166 | P15509 | |
| TGASQARPHAYYALS | 21 | P35462 | |
| CAPNSVVHGYQIRYS | 601 | Q8WUT4 | |
| LYSSQSEAVLYPVCH | 551 | Q13615 | |
| AATEYARACSHAGYP | 361 | Q3ZCN5 | |
| SPYTPTYAHLAAVAC | 1346 | Q9P2P1 | |
| HRSYGDASFCYDPVS | 291 | Q3ZCT8 | |
| YGVPFHQYTLGCVSE | 51 | Q99983 | |
| HYGCASFIYLRPTAN | 271 | Q8NGX6 | |
| HDNTYYCTAENPSGK | 96 | O60469 | |
| YLAAPRGACYGADHD | 526 | Q6NUM9 | |
| GVYSYDCSFGHVPNV | 296 | Q5T011 | |
| SYEYVDCRGNASVPH | 241 | Q96A25 | |
| ADYDPYAVAGVCNDH | 571 | Q9Y5W8 | |
| SGTVENIDYPHYCDL | 21 | A4D263 | |
| SGKVHLCVARYSYNP | 166 | O15034 | |
| SHRECQQPHYYGSEV | 341 | P00749 | |
| VQTYSCLSYGPVAYH | 321 | Q9NQ40 | |
| CLSYGPVAYHLAATL | 326 | Q9NQ40 | |
| SCAPAYVPYAAQAAL | 141 | Q6BEB4 | |
| NRTHLYVCGTGAYNP | 126 | Q13275 | |
| ELYYTLHAPDASGGC | 231 | Q6IEE7 | |
| GLTALTYHYETQCLP | 196 | Q9BU23 | |
| GNKSYVCHYAALGPE | 796 | Q6T4R5 | |
| EECAITYSNSHGPYD | 476 | P0DPF3 | |
| CQPYGSSFYALEEKH | 1291 | Q6P3W6 | |
| CQPYGSSFYALEEKH | 2511 | Q6P3W6 | |
| ECAITYSNSHGPYDS | 206 | A0A087WUL8 | |
| CQPYGSSFYALEEKH | 776 | A0A087WUL8 | |
| CQPYGSSFYALEEKH | 1996 | A0A087WUL8 | |
| CQPYGSSFYALEEKH | 3216 | A0A087WUL8 | |
| CQPYGSSFYALEEKH | 676 | P0DPF2 | |
| CQPYGSSFYALEEKH | 1896 | P0DPF2 | |
| CQPYGSSFYALEEKH | 3116 | P0DPF2 | |
| CQPYGSSFYALEEKH | 4336 | P0DPF2 | |
| GYLGYPTLCEQDQAH | 381 | Q8IXI1 | |
| SLYSSYHQGCLVNPT | 176 | Q6NSW7 | |
| YQSYVIHGCLENNPT | 176 | Q8IV61 | |
| PDDLIGCSAYEYIHA | 266 | Q9Y2N7 | |
| SYPETHIICNSYGCT | 696 | O15357 | |
| PSLIHYAGCYGQEKI | 421 | Q9Y6H5 | |
| QIGRSQSASYYPVCH | 1716 | Q9HCD6 | |
| LYNVEHTCGTTAPHY | 176 | Q8TBZ3 | |
| TLGLLDCTYSIHVYP | 196 | Q6UXD5 | |
| GSHVQYRCLPGYSLE | 726 | Q6UXD5 | |
| HYYEQTRGGQVSVCP | 481 | P11215 | |
| PAHALQHYLSCGGSY | 306 | Q9ULL5 | |
| NASHLYVCGTYAFQP | 121 | Q9C0C4 | |
| YLRPSCTGYIDHDIS | 46 | Q8IXM7 | |
| TPVVQDCYHGDGQSY | 371 | P00747 | |
| SYEEAVYGSSGHCVP | 176 | Q92537 | |
| ALYYPLAACATAGHT | 156 | Q9BX79 | |
| QPYNKTHIYVCGTGA | 136 | O95025 | |
| PKNADGTICYDSTHY | 126 | P14550 | |
| NGCSPSHSIVDGYYE | 146 | Q8TED9 | |
| VIGYVTNINHPCYSL | 176 | P09496 | |
| TYSGLFCVVVNPYKH | 116 | P35749 | |
| HYANVACAQLGFPSY | 136 | P57727 | |
| GNLADQLYYPCEHVA | 96 | Q96HA9 | |
| HNYSTGVSQDLFPYC | 191 | Q8WUH2 | |
| SLHTDGENSCRYYPM | 666 | Q86Y38 | |
| SCYSLEDSLSPEHNY | 1631 | O60673 | |
| KACEVARAHNYYPGS | 186 | Q76I76 | |
| CESVYPVVYASHRGL | 426 | Q9UJ98 | |
| YDCLPLYHSAGNIIG | 286 | Q6PCB7 | |
| IVYDCLPLYHSAGNI | 281 | Q6P1M0 | |
| ADLGAQYITCTPHYA | 56 | Q5VYX0 | |
| GSYNTFRLHSPCALY | 516 | O95935 | |
| TPGTHYQLDVQLYHC | 611 | P35590 | |
| IPSCGKSYGYHINDD | 91 | Q8N412 | |
| RAYQALHCPTGTEYT | 81 | Q96RU7 | |
| HGTVVEFYCDPGYSL | 266 | Q5VX71 | |
| CLDRHVAYGGYSTPE | 1316 | Q9HBL0 | |
| KTSCEYVSLYHQPAA | 361 | O60667 | |
| SYLCHAVSAPYASLA | 221 | P35504 | |
| GPCRYNLIAVSNHYG | 871 | Q9Y4E8 | |
| SHLVTGYCTYLPFQR | 1311 | P53804 | |
| QTLGYHVYPTCRNTS | 956 | O43847 | |
| PLLATYGVTAYLCGH | 226 | P13686 | |
| YYGTNGVCFPLHSED | 556 | Q9HBX9 | |
| HAYTLYSAVRPFGCS | 121 | P25788 | |
| LACHAEAYPANLTYS | 246 | Q9P2J2 | |
| DYNHLVTLCNGTYEG | 291 | P40126 | |
| HADPRSETGQYATYC | 946 | Q9ULM0 | |
| FHCTQYIRHGSDPLY | 296 | Q8IWU9 | |
| VPLHNACSYGHYEVT | 246 | Q9H2K2 | |
| VPLHNACSYGHYEVA | 561 | Q9H2K2 | |
| GEEAPSHLYYCQLEA | 551 | Q6ZN44 | |
| QRAYGPYSVTNCGEH | 371 | P29350 | |
| PQHSVDRIYSALYAC | 236 | Q9HC78 | |
| RSYSYPHCTGISQQD | 81 | Q53FD0 | |
| LRHYVVHSGENPYEC | 331 | O43296 | |
| VPQYIDYCHNSGAVL | 931 | Q7Z7G8 | |
| LEGLCSASVIYHYPG | 246 | Q96Q05 | |
| DYGYERHSNGQCLPA | 731 | Q8WY21 | |
| ARGCSTGNEKYHLPY | 96 | Q6PDA7 | |
| VNIYGDTPLHLACYN | 266 | Q59H18 | |
| SIYQDPVSLGCEHYF | 16 | Q9BVG3 | |
| TRSLNYCGHIYTPIS | 696 | Q93009 | |
| HDESAIYPVGYCSTR | 206 | Q3YBR2 | |
| IKPIYNLYAISCHSG | 1506 | Q8NFA0 | |
| ESPCQLHGRFYLYTD | 971 | Q562E7 | |
| SAAYIPAHTYACSFE | 266 | Q9NS93 | |
| AGTATCLVYGDPHYV | 1151 | Q9Y493 | |
| GSAQHPAVYTQICKY | 251 | O43240 | |
| VHICHNQDGYSYPSR | 836 | P01130 | |
| HPLTFNYSGVYICKV | 326 | Q9NQS3 |